Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55883, first published .
Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Journals

  1. Tang J, Song T, Kuang M, Liu H. Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review. Therapeutic Advances in Chronic Disease 2025;16 View
  2. Yu B, Li Y, Ma C, Reinhardt J, Dou Q, Zuo H, Yang X, Li M, Cai C, Fan Y, Huang Z, Pang T, Tang Q, Yang F, Ye T, Jia P, Yang S. Effectiveness of socioecological model-guided, smart device-based, and self-management-oriented lifestyle (3SLIFE) intervention on healthy lifestyles and metabolic syndrome risk in community residents: a cluster-randomized controlled trial. BMC Medicine 2025;23(1) View
  3. Zhang T, Su D, Li S, Yang Y. Dropping out or Moving on? A Systematic Review With Meta‐Aggregation of the Experience of Prehabilitation Among Patients With Cancer. Journal of Clinical Nursing 2025 View
  4. Wright P, Burts C, Harmon C, Corbett C. Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review. JMIR Infodemiology 2025;5:e68469 View
  5. Pan Y, Tang J, Lu B, Kuang M, Zhao M, Liu H, Zhong S. Effects of Cognitive Behavioral Therapy for Diet on Postprandial Glucose and Pregnancy Outcomes in Gestational Diabetes Mellitus: Multicenter Randomized Controlled Trial. Journal of Medical Internet Research 2025;27:e71075 View